Cunji Wang

机构：Hunan Academy of Traditional Chinese Medicine

发表论文 3 篇 · 总被引 24 次 · h-index 2

代表论文

• Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies (2025 · Signal Transduction and Targeted Therapy · 被引 14)
• Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRAS G12C mutation: Preliminary results from a pooled analysis of two phase I studies. (2023 · Journal of Clinical Oncology · 被引 10)
• Efficacy and Safety of IBI351 Monotherapy in KRASG12C-Mutated Metastatic Colorectal Cancer: Results from a Pooled Analysis of Phase I Part of Two Studies (2024 · SSRN Electronic Journal)